1391P Capmatinib vs docetaxel as second- or third-line (2/3L) therapy in patients (pts) with METex14-mutated advanced NSCLC (aNSCLC): The GeoMETry-III trial
Juan Vidal, O.J., Singhal, M.K., Alvarez, R.M., Cecere, F.L., Souquet, P-J., Kim, S-W., Robeva, A., Jary, A., Glaser, S., Miskic, M., Wolf, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1254MO Safety and anti-tumour activity of zipalertinib in NSCLC patients (pts) with EGFR exon 20 insertion (ex20ins) mutations who received prior amivantamab
Passaro, A., Yu, H.A., Nguyen, D., Lee, V.H.F., Soo, R.A., Kim, S.H., Daga, H., Tan, D.S.W., Kim, S-W., Juan Vidal, O.J., Piotrowska, Z., Keeton, E.K., Liu, T., Li, S., Jones, J., Ruiter, G.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
LBA57 Adagrasib (ADA) vs docetaxel (DOCE) in patients (pts) with KRASG12C-mutated advanced NSCLC and baseline brain metastases (BM): Results from KRYSTAL-12
Barlesi, F., Yao, W., Duruisseaux, M., Doucet, L., Shi, J., Juan Vidal, O.J., Kim, Y-C., García Campelo, M.R., Azkárate Martínez, A., Lu, S., Jotte, R., Felip, E., Lo Russo, G., Reck, M., Zhang, Y., Hu, N., Michenzie, M.F., Mok, T.S.K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1410P Characterization of patients with advanced non-small-cell lung cancer (NSCLC) harboring KRASG12C mutation and their associated direct healthcare costs in Spanish routine clinical practice (SILK study)
Reguart Aransay, N., Sánchez, J., Juan Vidal, O.J., Aguilo Domingo, M., Arriola, E., López, C., Botella, X., Cots, F., Montironi, C., Palanca, S., Borràs, E., Masfarre Pinto, L., Planellas, L., Lloansi Vila, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1312P Datopotamab deruxtecan (Dato-DXd) vs docetaxel (DTX) in patients (pts) with advanced nonsquamous (NSQ) non-small cell lung cancer (NSCLC) with brain metastases (mets): Results from TROPION-Lung01
Pons-Tostivint, E., Okamoto, I., Sands, J., Girard, N., Cornelissen, R., Hong, M.H., Paz-Ares, L.G., Vicente Baz, D., Sugawara, S., Cobo Dols, M., Pérol, M., Mascaux, C., Kitazono, S., Hayashi, H., Lisberg, A.E., Juan Vidal, O.J., Zhang, Y., Chargualaf, M., Uema, D., Ahn, M-J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
164P A spatially informed transcriptomic model to forecast early resistance to front-line osimertinib in advanced EGFR-mutant NSCLC
Zugazagoitia, J., Ruiz de Garibay, G., Pineda, S., Roch, B., Lopez, P. Garrido, Isla Casado, M.D., Vathiotis, I., Aguado, C., Perez, A. Callejo, Fabregat, R. Marse, Campelo, M.R. García, Cordellat, A. Blasco, Syrigos, K., Caro, R. Bernabe, Vidal, O.J. Juan, Gallego, E. Conde, Fuster, B. Hernando, Macintyre, G., Paz-Ares, L.G., Álvarez, M. Peressini
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1284P Clinical utility of liquid biopsy for non-small cell lung cancer patients with ALK fusion variants treated with brigatinib
Robado de Lope, L., García Campelo, M.R., Azkárate Martínez, A., Cobo Dols, M., Calvo de Juan, V., Nadal, E., Rodriguez Abreu, D., Callejo Perez, A., Dómine Gómez, M., Juan Vidal, O.J., Collazo Lorduy, A., Mosquera Martinez, J., Marse Fabregat, R., Mediavilla Medel, P., Serna-Blasco, R., Romero, A., Provencio Pulla, M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
LBA83 PECATI: A phase II trial to evaluate the efficacy and safety of lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma
Remon Masip, J., Bironzo, P., Girard, N., Bigay-Game, L., Juan Vidal, O.J., de Castro Carpeño, J., Reguart Aransay, N., Greillier, L., Cousin, S., Dansin, E., Majem, M., Bernabe Caro, R., Mosquera Martinez, J., Diaz, M., Meya, A., Alcalá-López, D., Sanz, A.G., Righi, L., Novello, S., Besse, B.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1640TiP PECATI: A phase II trial to evaluate the efficacy and safety of lenvatinib in combination with pembrolizumab in pretreated advanced b3-thymoma (B3-T) and thymic carcinoma (TC)
Remon Masip, J., Girard, N., Bironzo, P., Novello, S., De Castro Carpeno, J., Bigay-Game, L., Bernabe Caro, R., Greillier, L., Mosquera Martinez, J., Cousin, S., Juan Vidal, O.J., Sampayo-Cordero, M., Besse, B.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1192TiP GALLANT-1: Galectin-3 (Gal-3) inhibitor, GB1211, plus atezolizumab (atz) in patients (pts) with non-small cell lung cancer (NSCLC) - a dose finding study followed by a randomised, double-blind, placebo-controlled trial
Ghiringhelli, F., Barre, P., Pichon, E., Ponce Aix, S., Juan Vidal, O.J., Carcereny Costa, E., Sethi, T., Lindmark, B., MacKinnon, A., Aslanis, V., Phung, D.H., Jensen, P., Rajiwate, Z., Ross, G., Basse, L.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1630P Effectivity and safety of anti-SARS-CoV2 vaccination in patients with lung cancer: The VAC-CaP observational study (GECP 21/01)
Nadal, E., Moran Bueno, M.T., Rodriguez Abreu, D., Vidales Sepulveda, Z., Sala Gonzalez, M.A., Antonanzas Basa, M., Garcia Gonzalez, J.J., Diz Tain, P., Martinez Kareaga, M., Lopez Vivanco, G., Baena Espinar, J., Campos Balea, B., Cumplido Buron, D., Cerezo Gonzalez, S., Diaz, A., Guirado, M., Mielgo Rubio, X., Juan Vidal, O.J., Saigi Morgui, M., Provencio Pulla, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1049P Clinical outcomes in patients (pts) with tumor PD-L1 < 1% with first-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of chemotherapy (chemo) vs chemo alone for metastatic NSCLC (mNSCLC): Results from CheckMate 9LA
John, T., Ciuleanu, T-E., Cobo Dols, M., Schenker, M., Zurawski, B., Menezes, J., Richardet, E.A., Bennouna, J., Cheng, Y., Felip, E., Juan Vidal, O.J., Alexandru, A., Paz-Ares, L., Lu, S., Reck, M., Hu, N., Zhang, X., Grootendorst, D.J., Eccles, L., Carbone, D.P.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1010P Assessment of early resistance mechanisms to first-line osimertinib in EGFR-mutant NSCLC using spatial transcriptomics
Ruiz de Garibay, G., Roch, B., Garrido Lopez, P., Isla, D., Aguado, C., Callejo Perez, A., Marse Fabregat, R., Garcia Campelo, M.R., Blasco Cordellat, A., Sanchez Torres, J.M., Bernabe Caro, R., Juan Vidal, O.J., De Castro Carpeno, J., Franco, F.F., Ramos Garcia, I., Gomez Rueda, A., Conde Gallego, E., Ponce Aix, S., Paz-Ares, L., Zugazagoitia, J.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
39P Determination of essential biomarkers in lung cancer: A real-world data study in Spain
Calvo de Juan, V., Cobo Dols, M., Rodriguez-Abreu, D., Carcereny, E., Cantero, A., Bernabé Caro, R., Benitez Lopez, G., Lopez Castro, R., Massuti Sureda, B., del Barco, E., Garcia Campelo, M.R., Guirado, M., Camps Herrero, C.J.C., Ortega Granados, A.L.O., Gonzalez-Larriba, J.L., Sanchez Hernandez, A., Gonzalez Ojea, C., Sala Gonzalez, M.A., Juan Vidal, O.J., Provencio Pulla, M.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
53P Second-line treatment in advanced non-squamous (NS) non-small cell lung cancer (NSCLC) patients in Spain, analyzed in the Thoracic Tumor Registry (RTT)
Carcereny Costa, E., Collazo Lorduy, A., Cobo Dols, M., Rodriguez Abreu, D., Bernabé Caro, R., Lopez Castro, R., Massuti Sureda, B., del Barco, E., Guirado, M., Bosch-Barrera, J., Gonzalez-Larriba, J.L., Sanchez Hernandez, A., Juan Vidal, O.J., Oramas Rodriguez, J.M., Mosquera Martinez, J., Ortega Granados, A.L.O., Padilla, A., Moran Bueno, M.T., Cantero, A., Provencio Pulla, M.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
53P Real-world outcomes of first-line pembrolizumab (Pem) for metastatic non-small cell lung cancer (mNSCLC) with ≥50% expression of programmed cell death-ligand 1 (PD-L1): A multicentre retrospective study
Perea, J., Gómez, E., Escrivá, C., Pellicer, A.V., Rodriguez, P. Llor, Iranzo, J., Vidal, O.J. Juan, Sanchez, J. García, Montagud, G. Suay, Míco, A. Ferrero, Diaz, I. Linares, Sepúlveda, N. Gómez, Hernández, E. Soria, Gallego, J. Esteve, Carrasco, C., Gaudens, P. Capdevila
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
156P Development of a predictive model for early detection of lung cancer: SREAL-eLUNG study
Vidal, O.J. Juan, Lopez, M.E. Gas, Gómez, C. López, Monfort, A. Loras, Pardo, J.L. Valles, Suela, S. Palanca, Franch, N. Mancheño, Ansotegui, E., Medina, V. Calvo, Nuñez, C. Muñoz, Alvarez, F.J. Celada, Sanchís, B. Martínez, García, S. Marset, Esteban, J. Castejón, Cerviño, C. Cano, Alvarez, J. Medina, Rubia, G. Garcia, Mellen, A. Callejo, Martínez, B. Valdivieso
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)
Juan Vidal, O.J., Simarro, J., Lorente Estelles, D., Pérez-Simó, G., Mancheno, N., Murria, R., Gomez Codina, J., Laiz, B., Palanca, S.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I
Ponce Aix, S., Carcereny Costa, E., Bosch-Barrera, J., Felip Font, E., Guirado, M., Coves Sarto, J., Majem Tarruella, M., Juan Vidal, O.J., Dalmau Portulas, E., Diz, P., Ortega Granados, A.L.O., Domine Gomez, M., Blasco Cordellat, A., Mosquera Martinez, J., Sala Gonzalez, M.A., Dorta, M., Calvo de Juan, V., Zugazagoitia, J., Enguita, A.B., Paz-Ares, L.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
140P Preliminary results from PROPEL: A phase I/II study of bempegaldesleukin (BEMPEG: NKTR-214) plus pembrolizumab (PEMBRO) with or without chemotherapy in patients with metastatic NSCLC
Felip, E., Spigel, D.R., Juan Vidal, O.J., Beck, J.T., Aguado de la Rosa, C., Johnson, D.H., Spath-Schwalbe, E., Reinacher-Schick, A., Rodriguez Abreu, D., Altan, M., Reinmuth, N., Edelman, M.J., Reck, M., Zhao, Q., Banerjee, S., Chaudhry, S., Chien, D., Tagliaferri, M.A., Zalevsky, J., Ganti, A.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article